🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Medicines register
Registers Clinical trials Drugs API
Registers› Irish medicines
Medicines register · Ireland

Every medicine authorised for the Irish market

The Health Products Regulatory Authority's full list of authorised products — brand, active substance, licence holder, licence number and market status. Filter it, cite it, and take it away as a file.

Download CSV
Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,336 authorised products are in this register. Synced 20 Sep 2026, 17:51 UTC
Narrow the register Reset
Matches brand name, active substance, licence holder and licence number.
Browse by first letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
89 of 10,336 medicines
Download
Medicine
Active substance
Licence holder
Status
Intuniv 4 mg prolonged-release tablets EU/1/15/1040/008-009
GUANFACINE HYDROCHLORIDE
Takeda Pharmaceuticals International AG Ireland Branch
—
LIVTENCITY 200 mg film-coated tablets EU/1/22/1672/001-002
Maribavir
Takeda Pharmaceuticals International AG Ireland Branch
—
Mezavant XL 1200 mg gastro-resistant, prolonged release tablets PA23211/004/001
Mesalazine
Takeda Pharmaceuticals International AG Ireland Branch
Marketed
NINLARO 2.3 mg hard capsules EU/1/16/1094/001
Ixazomib citrate
Takeda Pharma A/S
—
NINLARO 3 mg hard capsules EU/1/16/1094/002
Ixazomib citrate
Takeda Pharma A/S
—
NINLARO 4 mg hard capsules EU/1/16/1094/003
Ixazomib citrate
Takeda Pharma A/S
—
PANTOZOL Control 20 mg Gastro-resistant tablet EU/1/09/517/001-004
Pantoprazole sodium sesquihydrate
Takeda GmbH
—
Plenadren 20 mg modified-release tablets EU/1/11/715/002
Hydrocortisone
Takeda Pharmaceuticals International AG Ireland Branch
—
Plenadren 5 mg modified-release tablets EU/1/11/715/001
Hydrocortisone
Takeda Pharmaceuticals International AG Ireland Branch
—
PROSTAP 3 DCS 11.25 mg Powder and Solvent for Prolonged-release Suspension for Injection in Pre-filled Syringe PA2229/009/001
Leuprorelin acetate
Takeda Products Ireland Ltd
Marketed
PROSTAP 6 DCS 30 mg Powder and Solvent for Prolonged-release Suspension for Injection in Pre-filled Syringe PA2229/009/002
Leuprorelin acetate
Takeda Products Ireland Ltd
Marketed
PROSTAP SR DCS 3.75 mg Powder and Solvent for Prolonged-release Suspension for Injection in Pre-filled Syringe PA2229/009/003
Leuprorelin acetate
Takeda Products Ireland Ltd
Marketed
Protium 20 mg gastro-resistant tablets PA2229/010/001
Pantoprazole sodium sesquihydrate
Takeda Products Ireland Ltd
Marketed
Protium 40 mg gastro-resistant tablets PA2229/010/002
Pantoprazole
Takeda Products Ireland Ltd
Marketed
Protium i.v. 40 mg Powder for Solution for Injection PA2229/010/003
Pantoprazole
Takeda Products Ireland Ltd
Marketed
Qdenga powder and solvent for solution for injection EU/1/22/1699/001
Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated
Takeda Pharmaceuticals International AG Ireland Branch
—
Qdenga powder and solvent for solution for injection EU/1/22/1699/002
Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated
Takeda Pharmaceuticals International AG Ireland Branch
—
Qdenga powder and solvent for solution for injection EU/1/22/1699/003
Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated
Takeda Pharmaceuticals International AG Ireland Branch
—
Qdenga powder and solvent for solution for injection EU/1/22/1699/004
Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated
Takeda Pharmaceuticals International AG Ireland Branch
—
Replagal 1 mg/ml concentrate for solution for infusion EU/1/01/189/001
Agalsidase alfa
Takeda Pharmaceuticals International AG Ireland Branch
—
Resolor 1 mg film-coated tablets EU/1/09/581/001
Prucalopride Succinate
Takeda Pharmaceuticals International AG Ireland Branch
—
Resolor 2 mg film-coated tablets EU/1/09/581/002
Prucalopride Succinate
Takeda Pharmaceuticals International AG Ireland Branch
—
Revestive 1.25 mg powder and solvent for solution for injection EU/1/12/787/003
Teduglutide
Takeda Pharmaceuticals International AG Ireland Branch
—
Revestive 5 mg powder and solvent for solution for injection EU/1/12/787/001
Teduglutide
Takeda Pharmaceuticals International AG Ireland Branch
—
SOMAC Control 20 mg Gastro-resistant tablet EU/1/09/516/001-004
Pantoprazole sodium sesquihydrate
Takeda GmbH
—
TAKHZYRO 150 mg solution for injection in pre-filled syringe EU/1/18/1340/007-009
LANADELUMAB
Takeda Pharmaceuticals International AG Ireland Branch
—
TAKHZYRO 300 mg solution for injection EU/1/18/1340/001
LANADELUMAB
Takeda Pharmaceuticals International AG Ireland Branch
—
Tyvense 20 mg capsules, hard PA23211/005/001
Lisdexamfetamine dimesylate
Takeda Pharmaceuticals International AG Ireland Branch
Marketed
Tyvense 30 mg capsules, hard PA23211/005/002
Lisdexamfetamine dimesylate
Takeda Pharmaceuticals International AG Ireland Branch
Marketed
Tyvense 40 mg capsules, hard PA23211/005/003
Lisdexamfetamine dimesylate
Takeda Pharmaceuticals International AG Ireland Branch
Marketed
Tyvense 50 mg capsules, hard PA23211/005/004
Lisdexamfetamine dimesylate
Takeda Pharmaceuticals International AG Ireland Branch
Marketed
Tyvense 60 mg capsules, hard PA23211/005/005
Lisdexamfetamine dimesylate
Takeda Pharmaceuticals International AG Ireland Branch
Marketed
Tyvense 70 mg capsules, hard PA23211/005/006
Lisdexamfetamine dimesylate
Takeda Pharmaceuticals International AG Ireland Branch
Marketed
Vipdomet 12.5 mg/1000 mg film-coated tablets EU/1/13/843/013-024
Alogliptin (as benzoate), Metformin Hydrochloride
Takeda Pharma A/S
—
Vipdomet 12.5 mg/850 mg film-coated tablets EU/1/13/843/001-012
Metformin Hydrochloride, Alogliptin (as benzoate)
Takeda Pharma A/S
—
Vipidia 12.5 mg film-coated tablets EU/1/13/844/010-018
Alogliptin (as benzoate)
Takeda Pharma A/S
—
Vipidia 25 mg film-coated tablets EU/1/13/844/019-027
Alogliptin (as benzoate)
Takeda Pharma A/S
—
Vipidia 6.25 mg film-coated tablets EU/1/13/844/001-009
Alogliptin (as benzoate)
Takeda Pharma A/S
—
Xagrid 0.5 mg hard capsules EU/1/04/295/001
Anagrelide hydrochloride
Takeda Pharmaceuticals International AG Ireland Branch
—
Showing 51–89 of 89
Previous 1 2
Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 28 September 2026. https://priyalifescience.com/medicines

Download this register
GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →
Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.